Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China’s Disposable Syringes Face Antidumping Investigation In Brazil

This article was originally published in PharmAsia News

Executive Summary

According to China Chamber of Commerce of Medicines & Health Products Importers & Exporters, a Brazilian corporation has applied for an antidumping investigation on China-made disposable plastic syringes. Currently, Brazil ranks as China's third largest export destination, with 340 million disposable syringes worth $91.7 million sold to Brazil in 2007. Industry figures show that China's 3 billion yuan disposable medical devices market is shared by more than 300 corporations. Excessive domestic competition has pushed more disposable medical device makers to sell their products at very low price overseas. The battle for market share and razor-thin profit margins have created a vicious cycle for these suppliers and the latest antidumping action represents another blow to the industry. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068240

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel